Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 4
1(50.0%)
2Total
N/A(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07534371Active Not Recruiting

Analysis of Optimal Treatment Sequencing of Surufatinib and Somatostatin Analogs in Neuroendocrine Tumors: A Retrospective Cohort Study

Role: collaborator

NCT07240753Not Yet Recruiting

A Chinese Cohort of Cervical Large Cell Neuroendocrine Carcinoma

Role: collaborator

NCT07185308Not ApplicableNot Yet Recruiting

Postbiotics Ameliorate Cachexia in Patients With Non-small-cell Lung Cancer

Role: collaborator

NCT06849466Phase 4Enrolling By Invitation

Effect of Perioperative Dexmedetomidine on Chronic Post-Surgical Pain

Role: collaborator

NCT06871891Not Yet Recruiting

Effect of Perioperative Sleep Quality on Chronic Post-Surgical Pain

Role: collaborator

All 5 trials loaded